miRNAtarget™ project: open for out-licensing and/or co-development partnership

Summary of invention:

Several miRNA compounds for cytoprotection in ischemic diseases, method of identification for cytoprotective miRNA targets, termed "protectomiRs".

IP status:

  • Patented technology (primary filing date Aug,  2011)
  • miRNAtarget, protectomiRpathomiRtherapomiRtoxicomiR, and diagnomiR are  trademarks of Pharmahungary

Potential investors and/or co-development partners, please contact us for further details at

(Please manually type the e-mail address in your e-mail client.)